Synthesis of benzimidazole-containing naphthalimide derivatives and applications of benzimidazole-containing naphthalimide derivatives on cancer resistance
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- DALIAN UNIV OF TECH
- Publication Date
- 2013-06-19
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the synthesis of a 4-(1H-benzimidazole-2-y1)-1,8-naphthalimide compound and its application in tumor cells, belonging to the technical fields of organic synthesis and medicinal chemistry. Background technique
[0002] Naphthalimide is a good precursor of DNA intercalator, and it is a research hotspot in recent years. The most famous derivatives that have been used clinically are amonafide (N-(β-dimethylaminoethyl)-3-amino-1,8-naphthalimide) and mitonafide (N-(β-di Methylaminoethyl)-3-nitro-1,8-naphthalimide), but because of its neurotoxic side effects, it has not entered clinical phase III. In order to improve the toxic and side effects and enhance the antitumor activity, the active site of naphthalimide is modified to synthesize new naphthalimide derivatives. The foreign Brana research group has reported a series of imidazonaphthimide derivatives, and the inhibitory activity of these derivatives to human colon cancer cells (...